< Back to latest news & events

Awards

HGF ranked in The Legal 500 Germany 2024

February 2024

HGF is proud to be ranked in The Legal 500 Germany 2024 guide.

The Legal 500 provides the most comprehensive worldwide coverage on recommended Law firms, Lawyers, Attorneys, Advocates, Solicitors, and Barristers. The rankings are based on a series of criteria including providing the most cutting edge and innovative advice to corporate counsel.

We have been ranked:

  • Tier 3 Firm for Patent Law: Patent Attorneys: Patent Litigation
  • Tier 4 Firm for Patent Law: Patent Attorneys: Patent Prosecution

For full rankings, click the button below.

FIND OUT MORE

Legal 500 comment: 

In addition to numerous European offices, HGF Europe LLP, which specialises in IP, also has an office in Munich, which is strategically important for patent law, and also impresses as a mixed patent and law firm with a holistic advisory approach. The practice’s management team consists of Markus Zoller (Life Sciences, Pharma and Genetic Engineering), Jan Robert Naefe (Materials Science) and Bernhard Ganahl (Physics and Engineering).

About Legal 500

Legal 500 is the leading guide to law firms in Germany. It offers all of those buying legal services in Germany reliable and up-to-date information on the very best firms and individuals operating in a dynamic legal market.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article
See all updates